DARWIN AG
7V0 | MU
Overview
Corporate Details
- ISIN(s):
- DE000A3C35W0
- LEI:
- 391200XJOD6U0EW7OE14
- Country:
- Germany
- Address:
- Brienner Str. 7, 80333 München
- Website:
- https://darwin-biotech.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Darwin AG is the parent company of the Austrian Novogenia GmbH, which is one of Europe's leading biotechnology companies in the field of human genetics. The company's own laboratory carries out genetic analyses that are used in the diagnosis, treatment and prevention of diseases as well as in the production of individually designed food supplements and cosmetics. Novogenia sees itself as a partner to doctors, therapists, pharmacists, nutritionists and fitness trainers. By analyzing the respective genetic predisposition of the patient or customer, the aim is to ensure the best possible treatment or care for their needs. Darwin is also involved as an investor in the biotechnology and healthcare sector.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-10-01 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 255.3 KB | |
| 2024-09-10 00:00 |
Annual Audited Financial Statements
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 69.8 KB | |
| 2023-09-20 00:00 |
Regulatory News Service
Ergänzung der Veröffentlichung vom 05.01.2023
|
German | 8.2 KB | |
| 2023-08-11 00:00 |
Regulatory News Service
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 56.9 KB | |
| 2023-06-06 00:00 |
Regulatory News Service
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 217.2 KB | |
| 2023-03-21 00:00 |
Annual Audited Financial Statements
Jahresabschluss zum Geschäftsjahr vom 15.03.2021 bis zum 31.12.2021
|
German | 44.0 KB | |
| 2023-01-05 00:00 |
Annual Audited Financial Statements
Ergänzt am 20.09.2023
|
German | 169.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
Antibiotice S.A. | Romania | ATB |